MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Anti-Obesity Compound Library

MCE 站：Anti-Obesity Compound Library

Obesity is widely recognized as the largest ａnd fastest growing public health problem ａnd is associated with numerous chronic disorders including osteoarthritis, obstructive sleep apnea, gallstones, fatty liver disease, reproductive ａnd gastrointestinal cancers, dyslipidemia, hypertension, type 2 diabetes, heart failure, coronary artery disease, stroke, etc. Although obesity has long been associated with serious health issues, it has only recently been regarded as a disease in the sense of being a specific target for medical therapy. Obesity may be viewed as the dysregulation of two physiological functions, appetite regulation ａnd energy metabolism, which combine to create disordered energy balance. Consequently, developing obesity treatments that target novel pathways is a growing focus for both biopharmaceutical industries. MCE Anti-Obesity Compound Library owns a unique collection of 363 compounds, which mainly target signaling pathway of controlling appetite, fatty acid metabolism ａnd energy expenditure, etc. This library is a useful tool for discovery anti-obesity drugs.

Description & Advantages:

•   A unique collection of 363 obesity related compounds.

•   The major targets include Fatty Acid Synthase, DGAT, Acetyl-CoA Carboxylas, MCHR1 (GPR24), Stearoyl-CoA Desaturase (SCD), etc..

•   A useful tool for the discovery of anti-obesity drugs.

•   More detailed compound information with structure, IC₅₀, ａnd other chemical & biological data.

•   High purity validated by NMR ａnd LC/MS.

•   All compounds are in stock ａnd continuously updated.

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。